Latest / Stock Movers / Weekly Roundup: UnitedHealth Drops, Eli Lilly Surges, Netflix Rises
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, radio news, The.
- 0:08Speaker 2: Stock Movers Podcast, your roundup of companies making moves in
- 0:13Speaker 2: the stock market, harnessing the power of Bloomberg Data.
- 0:17Speaker 1: Everybody, It's Carol Masser and Tim Stenebeck from Bloomberg Business
- 0:20Speaker 1: Week Daily and Tim Ritz. You know, it was an
- 0:22Speaker 1: interesting week. It was a holiday shortened week, but we
- 0:24Speaker 1: definitely had some big movers we did.
- 0:27Speaker 3: I have my eye on a secret stock that I'm
- 0:30Speaker 3: going to tell you later, Carol.
- 0:31Speaker 1: Oh Man, I didn't realize this was going to be
- 0:33Speaker 1: a mystery game.
- 0:34Speaker 3: Yeah, it's a mystery game. I want to start though
- 0:36Speaker 3: with United Health Group. That's the one you've got your
- 0:38Speaker 3: eye on, right, Yeah, its like a historic move today.
- 0:40Speaker 1: It's your number one decliner in the SNP over the
- 0:42Speaker 1: last four days. So this past week it was down
- 0:45Speaker 1: about twenty four percent. Most of that fall happening on Thursday,
- 0:50Speaker 1: and it had to do with it cutting its annual forecast.
- 0:52Speaker 1: It reported its first earnings missing over a decade, and
- 0:55Speaker 1: it cited some rising medical costs that blindsided the company.
- 0:58Speaker 3: Yeah, so here's what happened. The performance The company was
- 1:00Speaker 3: affected by patients who were looking for care at a
- 1:03Speaker 3: higher rate and then expected and then quote unanticipated changes
- 1:07Speaker 3: in optim health care delivery business.
- 1:10Speaker 1: Yeah. Right, So it's interesting because they talked about those businesses.
- 1:15Speaker 1: Both segments have been hit by changes from the US
- 1:17Speaker 1: Medicare program meant to limit tactics that insurers used to
- 1:20Speaker 1: boost their revenue. And the report really did shock investors,
- 1:24Speaker 1: and so you wonder about how much of it has
- 1:26Speaker 1: to do with maybe a different business environment for these
- 1:29Speaker 1: types of companies going forward. And United health considered a
- 1:32Speaker 1: bell weather in the sector, so it really dragged down
- 1:34Speaker 1: the group overall. But again, United Healthcare the biggest decliner
- 1:38Speaker 1: in the S and P five hundred this past week.
- 1:39Speaker 3: Real quick, some numbers to ascribe to this. The previous
- 1:43Speaker 3: range that they had put out was twenty nine to
- 1:45Speaker 3: fifty to thirty dollars a share for its adjusted earnings
- 1:48Speaker 3: forecast for the year. They lowered that carol to twenty
- 1:52Speaker 3: six to twenty six to fifty a share.
- 1:53Speaker 1: Unbelievable, a haircut, unbelievable. All right, let's get to what
- 1:56Speaker 1: was the biggest gainer in the S and P five
- 1:58Speaker 1: hundred this past week. Week It was up about fifteen
- 2:01Speaker 1: percent for the week overall, and we're talking about Eli
- 2:04Speaker 1: Lilly again, this one most of it's gains to coming
- 2:07Speaker 1: on Thursday.
- 2:09Speaker 3: This as the company released results after its experimental pill
- 2:13Speaker 3: helped a patient shed weight and control blood sugar about
- 2:16Speaker 3: as well as ozempic. This, Carol, it's kind of seen
- 2:20Speaker 3: as the golden goose when it comes to this technology.
- 2:23Speaker 3: Think about this, a pill that can do what ozempic
- 2:26Speaker 3: the shot can do, and you don't have to actually
- 2:29Speaker 3: give yourself a shot. You can just take a pill.
- 2:31Speaker 1: It's pretty big deal, right right, you say golden goose,
- 2:33Speaker 1: Holy grail. Like people have been moving the momentum, and
- 2:36Speaker 1: we've seen other drug companies kind of play around with this,
- 2:39Speaker 1: but to see Lily come out with this, it makes
- 2:41Speaker 1: you wonder what it might mean for the other players.
- 2:44Speaker 1: We did see Novo down on Thursday as a result,
- 2:47Speaker 1: but Eli Lilly again the beginner of the week again
- 2:51Speaker 1: up about fifteen percent.
- 2:52Speaker 3: We also talked about some of the side effects that
- 2:54Speaker 3: can happen with these medications, and I brought up the
- 2:57Speaker 3: idea that, okay, maybe that's one room for improvement because
- 3:01Speaker 3: we have heard reports of some gi issues for some
- 3:04Speaker 3: of the patients who do take this medication. Right, you
- 3:06Speaker 3: got to remember night, not this one that we're speaking,
- 3:08Speaker 3: not the experimental one.
- 3:09Speaker 1: No, but they're made GLP ones, correct, and they're all
- 3:11Speaker 1: they aren't exactly the same thing. And some patients do
- 3:16Speaker 1: have some kind of side effects, if you will, from
- 3:18Speaker 1: certain medications, and that's why you see some patients they
- 3:21Speaker 1: move around from one drug to the next. All right,
- 3:23Speaker 1: what do you got for us this past week?
- 3:25Speaker 3: Okay, my mystery stock for you is Netflix. It wasn't
- 3:28Speaker 3: the best performer in the Nasdaq one hundred, but it
- 3:32Speaker 3: was the second best performer, up four point five percent
- 3:35Speaker 3: on the week, and Carol, that was actually before the
- 3:39Speaker 3: company even put out its earnings report. Interesting, some of
- 3:43Speaker 3: the move that we saw earlier in the week had
- 3:45Speaker 3: a lot to do with the company aimed to triple
- 3:48Speaker 3: its operating income by the year twenty thirty. This was
- 3:51Speaker 3: a report that came out in the Wall Street Journal.
- 3:54Speaker 3: The company also, according to the Journal, said that they
- 3:57Speaker 3: want to double revenue by twenty thirty. They've got this
- 4:00Speaker 3: to hit nine billion dollars in add revenue by twenty
- 4:02Speaker 3: thirty and then also to end twenty thirty with around
- 4:05Speaker 3: four hundred and ten million subscribers. So that news earlier
- 4:09Speaker 3: in the week helped move shares.
- 4:10Speaker 1: Yeah, so the stock before earnings, and we should point
- 4:13Speaker 1: out that they did report after the close on Thursday,
- 4:15Speaker 1: and we did see the stock pop two three, I
- 4:18Speaker 1: think even maybe four percent at one point in the aftermarket.
- 4:22Speaker 1: So it's certainly going to be one we're going to
- 4:23Speaker 1: be watching out for next week. All right, that's going
- 4:27Speaker 1: to do it. I'm Carol Master along with Tim Steneveek.
- 4:29Speaker 1: For more conversations like this, check out our new Stock
- 4:31Speaker 1: Movers podcast. Subscribe for five minute episodes on the biggest
- 4:35Speaker 1: winners and losers in the stock market. You can find
- 4:37Speaker 1: Stock Movers on Apple, Spotify, or anywhere you get your podcasts.
- 4:42Speaker 2: The Stock Movers podcast from Bloomberg Radio. Check back with
- 4:47Speaker 2: us throughout the day for the latest roundup of companies
- 4:49Speaker 2: making news on Wall Street and for the latest market
- 4:53Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:57Speaker 2: Bloomberg dot com, and on Applecarplay. And Andrew rod Auto
- 5:00Speaker 2: with the Bloomberg Business app. Mm hmm